These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

220 related articles for article (PubMed ID: 16843168)

  • 61. Significance of non-coding circular RNAs and micro RNAs in the pathogenesis of cardiovascular diseases.
    Zhao G
    J Med Genet; 2018 Nov; 55(11):713-720. PubMed ID: 30177556
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Gene expression profiling of human diseases by serial analysis of gene expression.
    Ye SQ; Usher DC; Zhang LQ
    J Biomed Sci; 2002; 9(5):384-94. PubMed ID: 12218352
    [TBL] [Abstract][Full Text] [Related]  

  • 63. MicroRNAs and the heart: small things do matter.
    Papoutsidakis N; Deftereos S; Kaoukis A; Bouras G; Giannopoulos G; Theodorakis A; Angelidis C; Hatzis G; Stefanadis C
    Curr Top Med Chem; 2013; 13(2):216-30. PubMed ID: 23470079
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Pharmacogenomics, personalized medicine, and heart failure.
    Mestroni L; Taylor MR
    Discov Med; 2011 Jun; 11(61):551-61. PubMed ID: 21712021
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Contrasting gene expression profiles in two canine models of atrial fibrillation.
    Cardin S; Libby E; Pelletier P; Le Bouter S; Shiroshita-Takeshita A; Le Meur N; Léger J; Demolombe S; Ponton A; Glass L; Nattel S
    Circ Res; 2007 Feb; 100(3):425-33. PubMed ID: 17234964
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Genetics of cardiovascular diseases: lessons learned from a decade of genomics research in Iceland.
    Arnar DO; Andersen K; Thorgeirsson G
    Scand Cardiovasc J; 2016; 50(5-6):260-265. PubMed ID: 27572422
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Prospects for personalized cardiovascular medicine: the impact of genomics.
    Ginsburg GS; Donahue MP; Newby LK
    J Am Coll Cardiol; 2005 Nov; 46(9):1615-27. PubMed ID: 16256859
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Atrial natriuretic peptide gene variants and circulating levels: implications in cardiovascular diseases.
    Rubattu S; Sciarretta S; Volpe M
    Clin Sci (Lond); 2014 Jul; 127(1):1-13. PubMed ID: 24611929
    [TBL] [Abstract][Full Text] [Related]  

  • 69. New advances in microarrays: finding the genes causally involved in disease.
    Napoli C; de Nigris F; Sica V
    Methods Mol Med; 2005; 108():215-33. PubMed ID: 16028687
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Microarray analysis reveals pivotal divergent mRNA expression profiles early in the development of either compensated ventricular hypertrophy or heart failure.
    Buermans HP; Redout EM; Schiel AE; Musters RJ; Zuidwijk M; Eijk PP; van Hardeveld C; Kasanmoentalib S; Visser FC; Ylstra B; Simonides WS
    Physiol Genomics; 2005 May; 21(3):314-23. PubMed ID: 15728335
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Genomewide association studies in cardiovascular disease--an update 2011.
    Zeller T; Blankenberg S; Diemert P
    Clin Chem; 2012 Jan; 58(1):92-103. PubMed ID: 22125304
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Novel genetic approaches to the resolution of complex diseases.
    Hamet P; Tremblay J
    Cas Lek Cesk; 2004; 143(10):651-6; discussion 656. PubMed ID: 15584612
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Trends in genomic analysis of the cardiovascular system.
    Moldovan L; Moldovan NI
    Arch Pathol Lab Med; 2002 Mar; 126(3):310-6. PubMed ID: 11860305
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Translational insights from single-cell technologies across the cardiovascular disease continuum.
    van Blokland IV; Groot HE; Franke LH; van der Wijst MGP; van der Harst P
    Trends Cardiovasc Med; 2022 Apr; 32(3):127-135. PubMed ID: 33667644
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Functional genetics.
    Marchetti G; Pinotti M; Lunghi B; Casari C; Bernardi F
    Thromb Res; 2012 Mar; 129(3):336-40. PubMed ID: 22100315
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Gene expression profiling of cardiovascular disease models.
    Shiffman D; Porter JG
    Curr Opin Biotechnol; 2000 Dec; 11(6):598-601. PubMed ID: 11102796
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Bioinformatics tools enabling u-statistics for microarrays.
    Wittkowski KM; Haider A; Sehayek E; Suárez-Fariñas M; Pellegrino M; Peshansky A; Coffran C; Coker S
    Conf Proc IEEE Eng Med Biol Soc; 2006; 2006():3464-9. PubMed ID: 17947031
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Peripheral blood gene expression profiling for cardiovascular disease assessment.
    Aziz H; Zaas A; Ginsburg GS
    Genomic Med; 2007; 1(3-4):105-12. PubMed ID: 18923935
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Discovering biomarkers associated and predicting cardiovascular disease with high accuracy using a novel nexus of machine learning techniques for precision medicine.
    DeGroat W; Abdelhalim H; Patel K; Mendhe D; Zeeshan S; Ahmed Z
    Sci Rep; 2024 Jan; 14(1):1. PubMed ID: 38167627
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Genomic approaches to identify and investigate genes associated with atrial fibrillation and heart failure susceptibility.
    Patel KK; Venkatesan C; Abdelhalim H; Zeeshan S; Arima Y; Linna-Kuosmanen S; Ahmed Z
    Hum Genomics; 2023 Jun; 17(1):47. PubMed ID: 37270590
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.